Dietetic & Nutritional Management of Adult Inpatients with Chronic Liver Disease

1. Introduction

Chronic liver disease (CLD) encompasses a spectrum of progressive conditionscirrhosis, hepatitis B/C, nonalcoholic fatty liver disease (NAFLD), and alcoholic liver disease. Hospitalised patients often present with malnutrition, sarcopenia, and metabolic derangements that directly influence morbidity, length of stay and survival. A structured, evidencebased nutrition plan is therefore a core component of multidisciplinary care.

2. Nutritional Assessment

Accurate assessment guides therapy. Recommended tools for adult inpatients include:

• Clinical screening: The Royal Free HospitalNutritional Prioritisation Score (RFHNPS) or Subjective Global Assessment (SGA) identifies risk within 24h of admission.
• Anthropometry: Midarm circumference, skinfold thickness, and handgrip strength provide rapid bedside estimates of muscle mass.
• Biochemical markers: Serum albumin, prealbumin, transferrin and vitamin levels assist but must be interpreted cautiously (inflamed liver can lower values independent of nutritional status).
• Imaging: CT or MRI crosssectional area of the psoas or lumbar muscles (L3) is the gold standard for sarcopenia quantification when available.
• Energy & protein needs: Calculated using indirect calorimetry when possible; otherwise, 3035kcal/kg ideal body weight (IBW) and 1.21.5g/kg IBW protein are accepted standards.

3. General Principles of Feeding

All adult inpatients with CLD should receive:

• Frequent meals: 67 small meals/fortified snacks every 23h to counteract the catabolic effect of fasting.
• Lateevening carbohydrate supplement: 100g complex carbohydrate (e.g., maltodextrin) reduces nighttime gluconeogenesis and muscle breakdown.
• Enteral nutrition (EN) preference: If oral intake < 60% of requirements for > 48h, initiate tube feeding rather than parenteral routes.
• Avoid prolonged fasting: Do not allow 12h without nutrition unless medically necessary.
• Individualisation: Adjust macronutrients based on etiology (e.g., NAFLD requires calorie restriction, alcoholic liver disease needs protein but limited simple sugars).

4. Macronutrient Management

4.1 Energy

Energy balance is critical. Overfeeding can raise hepatic venous pressure and precipitate encephalopathy, while underfeeding worsens sarcopenia.

4.2 Protein

Historically protein restriction was used to prevent hepatic encephalopathy (HE), but current evidence supports adequate protein intake for most patients.

• Standard recommendation: 1.21.5g/kg IBW/day.
• HE present: Do not reduce protein below 0.8g/kg; instead use branchedchain amino acid (BCAA) enriched formulas (e.g., 20% of protein from BCAA).
• Renal impairment: If eGFR<30mL/min/1.73m, moderate protein (0.81.0g/kg) while ensuring essential amino acids.

4.3 Carbohydrate

Carbohydrate should supply 4555% of total calories, focusing on complex, lowglycemic sources.

• Whole grains, legumes, fruits, and nonstarchy vegetables.
• Avoid excessive simple sugars, especially in alcoholic liver disease or NAFLD, to limit hepatic denovo lipogenesis.

4.4 Fat

Fat contributes 3035% of calories. Choose mediumchain triglycerides (MCT) and omega3 rich oils when possible.

• MCT: Rapidly oxidised, spared for patients with cholestasis.
• Omega3: 12g EPA/DHA daily may improve inflammation and steatosis.
• Limit saturated fat (<7% of total kcal) and transfat.

5. Micronutrient Considerations

Deficiencies are common and can worsen outcomes.

• VitaminA, D, E, K: Fatsoluble vitamins are often low due to malabsorption; supplement according to serum levels (e.g., vitaminD 8002000IU/day).
• Watersoluble vitamins: Bcomplex (especially thiamine) and folate should be replaced; thiamine 100mg IV before glucose infusion to prevent Wernickes.
• Zinc: 220mg zinc sulphate (50mg elemental zinc) daily improves HE and taste perception.
• Magnesium & Selenium: Replace if serum low; magnesium 300400mg/day often needed.

6. Specific Clinical Situations

6.1 Ascites

Protein restriction worsens sarcopenia and is not recommended. Sodium restriction (2g/day) is the mainstay, combined with diuretics. Provide diureticsparing highprotein, moderatecalorie meals.

6.2 Hepatic Encephalopathy

Key strategies:

• Maintain protein 1.0g/kg.
• Use BCAAenriched formulas or supplement with lactulose and rifaximin.
• Limit ammoniaproducing foods (e.g., highprotein red meat) only if tolerated.

6.3 PostLiver Transplant

Early aggressive nutrition is vital to prevent infection and graft dysfunction.

• Enteral feeding within 24h if oral intake <60%.
• Energy 3035kcal/kg; protein 1.52.0g/kg.
• Monitor triglycerides; immunosuppressants (e.g., steroids) increase glucose needs.

6.4 Alcoholic Liver Disease

Address alcohol withdrawal concurrently. Provide highprotein, highcalorie diet with adequate thiamine. Limit simple sugars to reduce further hepatic injury.

6.5 NAFLD / NASH

Weight reduction remains central (710% loss improves histology). Use a hypocaloric diet (500kcal deficit), emphasize Mediterraneanstyle foods, and limit fructose.

7. Route of Nutrition Delivery

**Enteral Nutrition (EN)** is preferred over parenteral nutrition (PN) whenever the gut is functional.

• **Nasogastric (NG) tube** shortterm (<4weeks) or when oral intake insufficient.
• **Percutaneous endoscopic gastrostomy (PEG)** for prolonged feeding (>4weeks) and in patients with stable encephalopathy.
• **Jejunostomy** considered if high risk of aspiration or severe reflux.

If EN is contraindicated (e.g., intestinal obstruction, severe ileus), initiate peripheral PN for up to 5days, then switch to central PN with careful monitoring of glucose, electrolytes, and liver function.

8. Monitoring and Reevaluation

Regular review ensures goals are met and complications are detected early.

• **Weight & fluid balance:** Daily weights; adjust sodium and diuretic therapy.
• **Biochemistry:** Glucose, electrolytes, liver panel, INR, and vitamin levels 23 times/week.
• **Nutritional intake:** Record actual vs. prescribed calories/protein each shift.
• **Functional status:** Handgrip strength or chairrise test weekly.
• **Complications:** Monitor for refeeding syndrome (phosphate <0.5mmol/L, hypokalemia, hypomagnesemia) during the first 72h of feeding.

9. Practical Food and Fluid Guidelines

10. Discharge Planning

Transitioning to community care must include:

• Written individualized diet prescription.
• Education on portion sizes, lowsodium cooking, and alcohol abstinence.
• Referral to outpatient dietitian for followup within 12 weeks.
• Homebased supplementation plan for vitamins, zinc, and BCAA if indicated.

11. Conclusion

Effective dietetic and nutritional management of adult inpatients with chronic liver disease hinges on early assessment, tailored macronutrient delivery, correction of micronutrient deficits, and vigilant monitoring. By integrating these strategies into routine inpatient care, clinicians can reduce complications, preserve muscle mass, and improve overall prognosis.